Fairscale Capital’s Amgen AMGN Stock Holding History

Fairscale Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$337K	Hold	959	–	–	0.23%	68
2025 Q4	$314K	Hold	959	–	–	0.21%	69
2025 Q3	$271K	Hold	959	–	–	0.19%	75
2025 Q2	$283K	Hold	959	–	–	0.21%	71
2025 Q1	$299K	Hold	959	–	–	0.27%	56
2024 Q4	$250K	Hold	959	–	–	0.22%	65
2024 Q3	$309K	Hold	959	–	–	0.27%	57
2024 Q2	$319K	Buy	+959	New	+$282K	0.28%	59

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fairscale Capital's AMGN Position: Q1 2026 in Review

Fairscale Capital held its Amgen (AMGN) position steady in Q1 2026 at 959 shares worth $337K. The position accounts for 0.23% of the portfolio, ranked #68.

Fairscale Capital first reported a position in AMGN in Q2 2024 and has held it in 8 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Fairscale Capital held 959 shares of Amgen worth $337K as of Q1 2026.
Fairscale Capital left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.23% of Fairscale Capital's portfolio in Q1 2026, its #68 holding.
Fairscale Capital first reported a position in Amgen in Q2 2024 and has held it in 8 quarters since.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fairscale Capital's 13F filing for Q1 2026, filed 11 May 2026.